臨床婦人科産科69巻9号

2015年09月発行

今月の臨床 がん妊孕性温存治療の適応と注意点─腫瘍学と生殖医学の接点 婦人科腫瘍学 : 卵巣腫瘍

2．上皮性悪性腫瘍に対する妊孕性温存手術

著者： 佐藤豊実¹

所属機関： ¹筑波大学医学医療系産科婦人科学

ページ範囲：P.862 - P.866

●卵巣癌では，非明細胞腺癌IA／IC期高・中分化型とIA期明細胞腺癌には妊孕性温存手術（FSS）の選択が可能である．

●卵巣癌G3は妊孕性温存手術を行うことで予後を不良にする可能性があり，この選択は推奨できない．

●今後は，卵巣組織凍結や遺伝性卵巣癌にも留意してFSS適応の限界を探る必要がある．

参考文献

1） Brännström M, et al : Livebirth after uterus transplantation. Lancet 385 : 607─616, 2015

2） Kisu I, et al : Uterine allotransplantation in cynomolgus macaque : a preliminary experience with non-human primate models. J Obstet Gynaecol Res 40 : 907─918, 2014

3） 日本がん・生殖医療研究会 : がん治療と妊娠─がん治療後の将来を見据えて．卵巣組織凍結について．URL : http://www.j-sfp.org/ovarian/index.html

4） Satoh T, et al : Outcome of fertility-sparing surgery for stage I epithelial ovarian cancer : A proposal for patient selection. J Clin Oncol 28 : 1727─1732, 2010

5） Kajiyama H, et al : Fertility-sparing surgery in young women with invasive epithelial ovarian cancer. Eur J Surg Oncol 36 : 404─408, 2010

6） Kajiyama H, et al : Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery : a multi-institutional study. Eur J Obstet Gynecol Reprod Biol 175 : 97─102, 2014

7） Fruscio R, et al : Conservative management of early-stage epithelial ovariancancer : results of a large retrospective series. Ann Oncol 24 : 138─144, 2013

8） Nam JH, et al : Fertility-sparing surgery for young women with early-stage epithelial ovarian cancer. Gynecol Obstet Invest 76 : 14─24, 2013

9） Zapardiel I, et al : Conservative treatment of early stage ovarian cancer : oncological and fertility outcomes. Eur J Surg Oncol 140 : 387─393, 2014

10） Ditto A, et al : Long-term safety of fertility sparing surgery in early stage ovarian cancer : comparison to standard radical surgical procedures. Gynecol Oncol, 2015［Epub ahead of print］

11） Trimbos JB, et al : Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma : European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 95 : 113─125, 2003

12） 天神林友梨，佐藤豊実 : 卵巣癌に対する妊孕性温存手術の個別化．臨婦産69 : 106─112, 2015

13） Zanetta G, et al : Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynecol 104 : 1030─1035, 1997

14） Schilder JM, et al : Outcome of reproductive age women with stage Ia or Ic invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 87 : 1─7, 2002

15） Morice P, et al : Conservative treatment in epithelial ovarian cancer : results of a multicentre study of the GCCLCC（Groupe des Chirurgiens de Lutte Contre le Cancer） and SFOG（Societe Francaise d’Oncologie Gynecologique）. Hum Reprod 20 : 1379─1385, 2005

16） Park JY, et al : Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer : Oncologic safety and reproductive outcomes. Gynecol Oncol 110 : 345─353, 2008

17） Dolmans MM, et al : A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet 30 : 1289─1299, 2013

18） Pal T, et al : BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104 : 2807─2816, 2005

19） Risch HA, et al : Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances : a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98 : 1694─1706, 2006

20） Risch HA, et al : Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68 : 700─710, 2001

21） Rubin SC, et al : Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med 335 : 1413─1416, 1996

22） Shaw PA, et al : Histopathologic features of genetically determined ovarian cancer. Int J Gynecol Pathol 21 : 407─411, 2002